Two ways cancer resists treatment are actually connected, with one activating the other
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...
Dec 18, 2018
0
50